Analyst Expectations for Alector’s Future
Over the past 3 months, 4 analysts have published their opinion on Alector (NASDAQ:ALEC) stock. These analysts are…
BTIG Maintains Buy on Alector, Lowers Price Target to $16
BTIG analyst Thomas Shrader maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $54 to $16.
Citigroup Maintains Buy on Alector, Lowers Price Target to $17
Citigroup analyst Neena Bitritto-Garg maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $19 to $17.
Important Biotech Catalysts For September 12, 2022 – End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ:MRSN) lead candidate…
Alector Initiates Phase 1 Clinical Trial Of AL044 For The Treatment Of Alzheimer’s Disease
AL044 is the first clinical-stage drug candidate targeting MS4A, a major genetic risk factor for AD
AL044, a novel first-in-class therapeutic candidate, seeks to counteract multiple AD pathologies through
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday.
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Friday. Here are some big stocks recording gains in today’s session.